Osteopontin in Cardiovascular Disease A Potential Therapeutic Target

被引：80
|
作者：
Waller, Alfonso H. [1 ]
Sanchez-Ross, Monica [1 ]
Kaluski, Edo [1 ]
Klapholz, Marc [1 ]
机构：
[1] UMDNJ, New Jersey Med Sch, Div Cardiol, Dept Med, Newark, NJ 07103 USA
来源：
CARDIOLOGY IN REVIEW | 2010年 / 18卷 / 03期
关键词：
osteopontin; myocardial infarction; heart failure; calcification; valvular disease; myocardial remodeling; MICROVASCULAR ENDOTHELIAL-CELLS; LEFT-VENTRICULAR DILATION; ANGIOTENSIN-II; PLASMA OSTEOPONTIN; MYOCARDIAL-INFARCTION; MESSENGER-RNA; ATHEROSCLEROTIC LESIONS; BONE SIALOPROTEIN; CARDIAC FIBROSIS; HEART-FAILURE;
D O I：
10.1097/CRD.0b013e3181cfb646
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Osteopontin (OPN), also known as 44kDa bone phosphoprotein, sialoprotein I, secreted phosphoprotein I, 2ar, uropontin, and early T-lymphocyte activation-1 (Eta-1), is a multifunctional protein. OPN has been found to be expressed in various cell types and species with many physiologic and pathologic functions. OPN has emerged as a potential biomarker and mediator in cardiovascular disease. In this review, we will discuss the roles of OPN in cardiovascular disease, specifically in vascular and valvular heart disease, myocardial infarction and heart failure.
引用
收藏
页码：125 / 131
页数：7
相关论文
共 50 条
  • [21] Telomerase as a Therapeutic Target in Cardiovascular Disease
    Hoffmann, Jedrzej
    Richardson, Gavin
    Haendeler, Judith
    Altschmied, Joachim
    Andres, Vicente
    Spyridopoulos, Ioakim
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (03) : 1047 - 1061
  • [22] Autophagy as a therapeutic target in cardiovascular disease
    Nemchenko, Andriy
    Chiong, Mario
    Turer, Aslan
    Lavandero, Sergio
    Hill, Joseph A.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 51 (04) : 584 - 593
  • [23] CaMKII as a Therapeutic Target in Cardiovascular Disease
    Gaido, Oscar E. Reyes
    Nkashama, Lubika J.
    Schole, Kate L.
    Wang, Qinchuan
    Umapathi, Priya
    Mesubi, Olurotimi O.
    Konstantinidis, Klitos
    Luczak, Elizabeth D.
    Anderson, Mark E.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2023, 63 : 249 - 272
  • [24] Toll-like receptors as a potential therapeutic target for atherosclerosis and cardiovascular disease
    Lacheta, Dominika
    Olejarz, Wioletta
    Wrzosek, Malgorzata
    Nowicka, Grazyna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2018, 72 : 728 - 739
  • [25] GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease-A Systematic Review
    Mori, Yusaku
    Matsui, Takanori
    Hirano, Tsutomu
    Yamagishi, Sho-ichi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [26] HOMOARGININE AND CARDIOVASCULAR PROTECTION: POTENTIAL THERAPEUTIC TARGET?
    Mels, Catharina M. C.
    Mokhaneli, Maserame Cleopatra
    Boeger, Rainer
    Schwedhelm, Edzard
    Le Roux, Shani Botha
    JOURNAL OF HYPERTENSION, 2023, 41 : E29 - E30
  • [27] Ferroptosis: A Potential Target in Cardiovascular Disease
    Leng, Yanlong
    Luo, Xing
    Yu, Jiaying
    Jia, Haibo
    Yu, Bo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [28] Matrix metalloproteinases: A therapeutic target in cardiovascular disease
    Sierevogel, MJ
    Pasterkamp, G
    de Kleijn, DPV
    Strauss, BH
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (13) : 1033 - 1040
  • [29] Rho kinase as a therapeutic target in cardiovascular disease
    Surma, Michelle
    Wei, Lei
    Shi, Jianjian
    FUTURE CARDIOLOGY, 2011, 7 (05) : 657 - 671
  • [30] Senescent cells: a therapeutic target for cardiovascular disease
    Childs, Bennett G.
    Li, Hu
    van Deursen, Jan M.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (04): : 1217 - 1228
12345